Skip to main content

Carcinogenesis of Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

  • Chapter
  • First Online:
Mechanisms of Oncogenesis

Part of the book series: Cancer Growth and Progression ((CAGP,volume 12))

  • 883 Accesses

Abstract

Head and neck squamous cell carcinoma is the most common head and neck malignant tumor. Much progress has been made in studying its carcinogenesis, though it is still an open question. Human papillomavirus (HPV) has been shown to play a possible role in the carcinogenesis of head and neck squamous cell carcinoma. Similar to its role in human uterus cervical cancer, HPV has been identified in association with head and neck squamous cell carcinoma, esp. those arising from tonsil. Based on its correlation with squamous cell carcinoma, HPV is divided into two groups: high and low risk groups. HPV 16 in the high risk group is most common variant associated with head and neck squamous cell carcinoma. Two HPV genes (E6 and E7) are found to be necessary and sufficient to immortalize human keratinocytes. The E6 and E7 proteins bind to p53 and RB1 respectively and accelerate the degradation of these tumor suppressor gene products, which may partially contribute to the carcinogenesis of head and neck squamous cell carcinoma. HPV can be detected by different methods on different type of specimens. The methods include immunohistochemistry, in situ hybridization, PCR, and signal amplification. Recently, an invader assay receives FDA approval for HPV in uterus cervical cancer. The method might also be used for head and neck squamous cell carcinoma after technical and clinical validation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJ. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer. 2002 Dec 26;2:37.

    Article  PubMed  Google Scholar 

  2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007 Jan–Feb; 57(1);43–66.

    Article  PubMed  Google Scholar 

  3. Leon B, Eveson JW, Reichart P, Sidransky D, editor. WHO classification of tumors: Pathology & genetics: Head and neck tumours. Lyon: IARC Press; 2005.

    Google Scholar 

  4. Dreibelbis D, editor. A textbook of histology. 11th ed. Philadelphia, PA: W. B. Saunders Company; 1986.

    Google Scholar 

  5. Joklik WK, Willett HP, Amos BD, Wilfert CM, editor. Zinsser microbiology. 20th ed. Norwalk, CT/San Mateo, CA: Appleton & Lange; 1992.

    Google Scholar 

  6. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology. 2004 Jun 20;324(1);17–27.

    Article  PubMed  Google Scholar 

  7. Brandsma JL, Abramson AL. Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg. 19 May;115(5);621–5.

    Google Scholar 

  8. Smith EM, Summersgill KF, Allen J, Hoffman HT, McCulloch T, Turek LP, et al. Human papillomavirus and risk of laryngeal cancer. Ann Otol Rhinol Laryngol. 2000 Nov;109(11);1069–76.

    CAS  PubMed  Google Scholar 

  9. Maden C, Beckmann AM, Thomas DB, McKnight B, Sherman KJ, Ashley RL, et al. Human papillomaviruses, herpes simplex viruses, and the risk of oral cancer in men. Am J Epidemiol. 1992 May 15;135(10);1093–102.

    CAS  PubMed  Google Scholar 

  10. Nishioka S, Fukushima K, Nishizaki K, Gunduz M, Tominaga S, Fukazawa M, et al. Human papillomavirus as a risk factor for head and neck cancers – a case-control study. Acta Otolaryngol Suppl. 1999;540:77–80.

    Article  CAS  PubMed  Google Scholar 

  11. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001 Apr 12;344(15);1125–31.

    Article  CAS  PubMed  Google Scholar 

  12. Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol. 1989 Oct;63(10);4417–21.

    CAS  PubMed  Google Scholar 

  13. Turek LP. The structure, function, and regulation of papillomaviral genes in infection and cervical cancer. Adv Virus Res. 1994;44:305–56.

    Article  CAS  PubMed  Google Scholar 

  14. Steger G, Corbach S. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J Virol. 1997 Jan;71(1);50–8.

    CAS  PubMed  Google Scholar 

  15. Jeon S, Allen-Hoffmann BL, Lambert PF. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol. 1995 May;69(5);2989–97.

    CAS  PubMed  Google Scholar 

  16. Park NH, Min BM, Li SL, Huang MZ, Cherick HM, Doniger J. Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis. 1991 Sep;12(9);1627–31.

    Article  CAS  PubMed  Google Scholar 

  17. Oda D, Bigler L, Lee P, Blanton R. HPV immortalization of human oral epithelial cells: A model for carcinogenesis. Exp Cell Res. 1996 Jul 10;226(1);164–9.

    Article  CAS  PubMed  Google Scholar 

  18. Spanos WC, Geiger J, Anderson ME, Harris GF, Bossler AD, Smith RB, et al. Deletion of the PDZ motif of HPV16 E6 preventing immortalization and anchorage-independent growth in human tonsil epithelial cells. Head Neck. 2008 Feb;30(2);139–47.

    Article  PubMed  Google Scholar 

  19. Pfeifer JD, editor. Molecular genetic testing in surgical pathology. Philadelphia, PA: Lippincott Williams & Wilkins; 2006.

    Google Scholar 

  20. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 990 Apr 6;248(4951);76–9.

    Google Scholar 

  21. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 1993 Nov 5;75(3);495–505.

    Article  CAS  PubMed  Google Scholar 

  22. Boyer SN, Wazer DE, Band V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 1996 Oct 15;56(20);4620–4.

    CAS  PubMed  Google Scholar 

  23. Khleif SN, DeGregori J, Yee CL, Otterson GA, Kaye FJ, Nevins JR, et al. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci USA. 1996 Apr 30;93(9);4350–4.

    Article  CAS  PubMed  Google Scholar 

  24. Ragin CC, Modugno F, Gollin SM. The epidemiology and risk factors of head and neck cancer: A focus on human papillomavirus. J Dent Res. 2007 Feb;86(2);104–14.

    Article  CAS  PubMed  Google Scholar 

  25. Strati K, Lambert PF. Role of rb-dependent and rb-independent functions of papillomavirus E7 oncogene in head and neck cancer. Cancer Res. 2007 Dec 15;67(24);11585–93.

    Article  CAS  PubMed  Google Scholar 

  26. Syrjanen K, Syrjanen S, Lamberg M, Pyrhonen S, Nuutinen J. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg. 1983 Dec;12(6);418–24.

    Article  CAS  PubMed  Google Scholar 

  27. Loning T, Ikenberg H, Becker J, Gissmann L, Hoepfer I, zur Hausen H. Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. J Invest Dermatol. 1985 May;84(5);417–20.

    Article  CAS  PubMed  Google Scholar 

  28. D’Costa J, Saranath D, Dedhia P, Sanghvi V, Mehta AR. Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol. 1998 Sep;34(5);413–20.

    Article  PubMed  Google Scholar 

  29. Matzow T, Boysen M, Kalantari M, Johansson B, Hagmar B. Low detection rate of HPV in oral and laryngeal carcinomas. Acta Oncol. 1998;37(1);73–6.

    Article  CAS  PubMed  Google Scholar 

  30. Sand L, Jalouli J, Larsson PA, Hirsch JM. Human papilloma viruses in oral lesions. Anticancer Res. 2000 Mar–Apr;20(2B):1183–8.

    CAS  PubMed  Google Scholar 

  31. Bouda M, Gorgoulis VG, Kastrinakis NG, Giannoudis A, Tsoli E, Danassi-Afentaki D, et al. “High risk” HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol. 2000 Jun;13(6);644–53.

    Article  CAS  PubMed  Google Scholar 

  32. Lind PO, Syrjanen SM, Syrjanen KJ, Koppang HS, Aas E. Local immunoreactivity and human papillomavirus (HPV) in oral precancer and cancer lesions. Scand J Dent Res. 1986 Oct;94(5);419–26.

    CAS  PubMed  Google Scholar 

  33. Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol. 2005 Mar; 32(Suppl. 1):S59–66.

    Article  PubMed  Google Scholar 

  34. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, et al. Human papillomavirus and oral cancer: The international agency for research on cancer multicenter study. J Natl Cancer Inst. 2003 Dec 3;95(23);1772–83.

    PubMed  Google Scholar 

  35. Koch WM, Lango M, Sewell D, Zahurak M, Sidransky D. Head and neck cancer in nonsmokers: A distinct clinical and molecular entity. Laryngoscope. 1999 Oct;109(10); 1544–51.

    Article  CAS  PubMed  Google Scholar 

  36. Wiseman SM, Swede H, Stoler DL, Anderson GR, Rigual NR, Hicks WL, Jr, et al. Squamous cell carcinoma of the head and neck in nonsmokers and nondrinkers: An analysis of clinicopathologic characteristics and treatment outcomes. Ann Surg Oncol. 2003 Jun;10(5);551–7.

    Article  PubMed  Google Scholar 

  37. Ishibashi T, Matsushima S, Tsunokawa Y, Asai M, Nomura Y, Sugimura T, et al. Human papillomavirus DNA in squamous cell carcinoma of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg. 1990 Mar;116(3);294–8.

    CAS  PubMed  Google Scholar 

  38. Bradford CR, Zacks SE, Androphy EJ, Gregoire L, Lancaster WD, Carey TE. Human papillomavirus DNA sequences in cell lines derived from head and neck squamous cell carcinomas. Otolaryngol Head Neck Surg. 1991 Mar;104(3);303–10.

    CAS  PubMed  Google Scholar 

  39. Fouret P, Monceaux G, Temam S, Lacourreye L, St Guily JL. Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. Arch Otolaryngol Head Neck Surg. 1997 May;123(5);513–6.

    CAS  PubMed  Google Scholar 

  40. Snijders PJ, Meijer CJ, van den Brule AJ, Schrijnemakers HF, Snow GB, Walboomers JM. Human papillomavirus (HPV) type 16 and 33 E6/E7 region transcripts in tonsillar carcinomas can originate from integrated and episomal HPV DNA. J Gen Virol. 1992 Aug;73(Pt 8):2059–66.

    Article  CAS  PubMed  Google Scholar 

  41. Wilczynski SP, Lin BT, Xie Y, Paz IB. Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol. 1998 Jan;152(1);145–56.

    CAS  PubMed  Google Scholar 

  42. Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene. 2002 Feb 28;21(10);1510–7.

    Article  CAS  PubMed  Google Scholar 

  43. Koskinen WJ, Chen RW, Leivo I, Makitie A, Back L, Kontio R, et al. Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer. 2003 Nov 10;107(3);401–6.

    Article  CAS  PubMed  Google Scholar 

  44. Rose Ragin CC, Taioli E. Second primary head and neck tumor risk in patients with cervical cancer – SEER data analysis. Head Neck. 2008 Jan;30(1);58–66.

    Article  PubMed  Google Scholar 

  45. Haddad R, Crum C, Chen Z, Krane J, Posner M, Li Y, et al. HPV16 transmission between a couple with HPV-related head and neck cancer. Oral Oncol. 2008 Aug;44(8);812–5.

    Article  PubMed  Google Scholar 

  46. Schlecht NF, Burk RD, Adrien L, Dunne A, Kawachi N, Sarta C, et al. Gene expression profiles in HPV-infected head and neck cancer. J Pathol. 2007 Nov;213(3);283–93.

    Article  CAS  PubMed  Google Scholar 

  47. Syrjanen KJ, Syrjanen S. Papillomavirus infections in human disease. New York: Wiley; 2000.

    Google Scholar 

  48. Syrjanen S. HPV infections and tonsillar carcinoma. J Clin Pathol. 2004 May;57(5);449–55.

    Article  CAS  PubMed  Google Scholar 

  49. Howell RE, Gallant L. Human papillomavirus type 16 in an oral squamous carcinoma and its metastasis. Oral Surg Oral Med Oral Pathol. 1992 Nov;74(5);620–6.

    Article  CAS  PubMed  Google Scholar 

  50. Snijders PJ, Scholes AG, Hart CA, Jones AS, Vaughan ED, Woolgar JA, et al. Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neck. Int J Cancer. 1996 May 16;66(4);464–9.

    Article  CAS  PubMed  Google Scholar 

  51. Snijders PJ, Steenbergen RD, Meijer CJ, Walboomers JM. Role of human papillomaviruses in cancer of the respiratory and upper digestive tract. Clin Dermatol. 1997 May–Jun;15(3);415–25.

    Article  CAS  PubMed  Google Scholar 

  52. Badaracco G, Venuti A, Morello R, Muller A, Marcante ML. Human papillomavirus in head and neck carcinomas: Prevalence, physical status and relationship with clinical/pathological parameters. Anticancer Res. 2000 Mar–Apr; 20(2B):1301–5.

    CAS  PubMed  Google Scholar 

  53. Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: A meta-analysis, 1982–1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Jun;91(6);622–35.

    Article  CAS  PubMed  Google Scholar 

  54. Ringstrom E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res. 2002 Oct;8(10);3187–92.

    PubMed  Google Scholar 

  55. Lin KY, Westra WH, Kashima HK, Mounts P, Wu TC. Coinfection of HPV-11 and HPV-16 in a case of laryngeal squamous papillomas with severe dysplasia. Laryngoscope. 1997 Jul;107(7);942–7.

    Article  CAS  PubMed  Google Scholar 

  56. Derkay CS, Darrow DH. Recurrent respiratory papillomatosis of the larynx: Current diagnosis and treatment. Otolaryngol Clin North Am. 2000 Oct;33(5);1127–42.

    Article  CAS  PubMed  Google Scholar 

  57. Derkay CS. Recurrent respiratory papillomatosis. Laryngoscope. 2001 Jan;111(1);57–69.

    Article  CAS  PubMed  Google Scholar 

  58. Rabah R, Lancaster WD, Thomas R, Gregoire L. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr Dev Pathol. 2001 Jan–Feb;4(1);68–72.

    Article  CAS  PubMed  Google Scholar 

  59. Velyvyte D, Laiskonis A, Uloza V, Gozdzicka-Jozefiak A. Prevalence of papillomavirus infection among patients with laryngeal papillomatosis and the effects of some risk factors on the persistence of papillomaviruses in the upper respiratory tract. Medicina (Kaunas). 2002;38(5);499–504.

    Google Scholar 

  60. Herrero R. Chapter 7 Human papillomavirus and cancer of the upper aerodigestive tract. J Natl Cancer Inst Monogr. 2003;31:47–51.

    PubMed  Google Scholar 

  61. Miller JJ, 3rd, Nossal GJ. Antigens in immunity. vi. the phagocytic reticulum of lymph node follicles. J Exp Med. 1964 Dec 1;120:1075–86.

    Article  PubMed  Google Scholar 

  62. Chen LL, Adams JC, Steinman RM. Anatomy of germinal centers in mouse spleen, with special reference to “follicular dendritic cells”. J Cell Biol. 1978 Apr;77(1);148–64.

    Article  CAS  PubMed  Google Scholar 

  63. NOSSAL GJ, ADA GL, AUSTIN CM. Antigens in immunity. iv. cellular localization of 125-I- and 131-I-labelled flagella in lymph nodes. Aust J Exp Biol Med Sci. 1964 Jun;42:311–30.

    Article  CAS  PubMed  Google Scholar 

  64. Chen LL, Frank AM, Adams JC, Steinman RM. Distribution of horseradish peroxidase (HRP)-anti-HRP immune complexes in mouse spleen with special reference to follicular dendritic cells. J Cell Biol. 1978 Oct;79(1);184–99.

    Article  CAS  PubMed  Google Scholar 

  65. Stein H, Spiegel H, Herbst H, Niedobitek G, Foss HD. Lymphoid tissues and AIDS: Role of lymphocytes and follicular dendritic cells (FDC). Verh Dtsch Ges Pathol. 1991;75:4–19.

    CAS  PubMed  Google Scholar 

  66. Stahmer I, Ordonez C, Popovic M, Ekmman M, Biberfeld G. SIV infection of follicular dendritic cells (FDC) and other spleen cell subsets in experimentally infected cynomolgus monkeys. Adv Exp Med Biol. 1995;378:321–7.

    CAS  PubMed  Google Scholar 

  67. Burton GF, Masuda A, Heath SL, Smith BA, Tew JG, Szakal AK. Follicular dendritic cells (FDC) in retroviral infection: Host/pathogen perspectives. Immunol Rev. 1997 Apr;156:185–97.

    Article  CAS  PubMed  Google Scholar 

  68. Smeets SJ, Hesselink AT, Speel EJ, Haesevoets A, Snijders PJ, Pawlita M, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer. 2007 Dec 1;121(11);2465–72.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dahui Qin .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Qin, D. (2010). Carcinogenesis of Human Papillomavirus in Head and Neck Squamous Cell Carcinoma. In: Coppola, D. (eds) Mechanisms of Oncogenesis. Cancer Growth and Progression, vol 12. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-3725-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-90-481-3725-1_12

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-90-481-3724-4

  • Online ISBN: 978-90-481-3725-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics